Data as of May 22
| +0.01 / +2.33%|
The 2 analysts offering 12-month price forecasts for A.P. Pharma Inc have a median target of 1.13, with a high estimate of 1.25 and a low estimate of 1.00. The median estimate represents a +155.68% increase from the last price of 0.44.
The current consensus among 2 polled investment analysts is to Buy stock in A.P. Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.